Driving Shareholder Returns
2
Safe Harbor Statement and Other Matters
This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any
statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar
expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements
may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory
inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect
demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans,
prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity
of intellectual property protection, cost reductions or savings targets, including those related to the closing of Chemours' Kuan Yin manufacturing site located in Taiwan, plans
to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost
savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements.
Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized, such as full year guidance relying on
models based upon management assumptions regarding future events that are inherently uncertain. These statements are not guarantees of future performance. Forward-
looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside our control, including general economic conditions and the COVID-
19 pandemic, have affected or may affect our business and operations and may or may continue to hinder our ability to provide goods and services to customers, cause
disruptions in our supply chains such as through strikes, labor disruptions or other events, adversely affect our business partners, significantly reduce the demand for our
products, adversely affect the health and welfare of our personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours
is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these
differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Quarterly Report on
Form 10-Q for the quarter ended September 30, 2023 and in our Annual Report on Form 10-K for the year ended December 31, 2022. Chemours assumes no obligation to
revise or update any forward-looking statement for any reason, except as required by law.
We prepare our financial statements in accordance with Generally Accepted Accounting Principles ("GAAP"). Within this presentation we may make reference to Adjusted Net
Income, Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Free Cash Flow, Free Cash Flow, Adjusted Effective Tax Rate, Return on Invested Capital
(ROIC) and Net Leverage Ratio which are non-GAAP financial measures. The company includes these non-GAAP financial measures because management believes they
are useful to investors in that they provide for greater transparency with respect to supplemental information used by management in its financial and operational decision
making. Further information with respect to and reconciliations of such measures to the nearest GAAP measure can be found in the appendix hereto.
Management uses Adjusted Net Income, Adjusted EPS, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Free Cash Flow, Free Cash Flow, Adjusted Effective Tax Rate,
ROIC and Net Leverage Ratio to evaluate the company's performance excluding the impact of certain cash and noncash charges and other special items which we expect to
be infrequent in occurrence in order to have comparable financial results to analyze changes in our underlying business from quarter to quarter.
Additional information for investors is available on the company's website at investors.chemours.com.
Chemours™View entire presentation